RESPONSE TO:
HM Government
A SMOKEFREE FUTURE
MHRA Consultation Letter MLX 364
THE REGULATION OF NICOTINE CONTAINING PRODUCTS
From Intellicig, UK manufacturer and marketer of electronic cigarettes.
Media release 05.02.10 For immediate use.
Electronic cigarette manufacturer backs Government call for
regulation but warns against forcing quitters back to deadly habit.
Intellicig, a leading and pioneering supplier of electronic cigarettes nicotine delivery
devices has backed MHRA calls for industry regulation and licensing and is supporting the
Department for Healths A Smokefree Future policy document issued on Monday.
A Smokefree Future calls for a radical and innovative approach to providing safer nicotine
products so that addicts can limit their exposure to the proven health risk of tobacco smoke
with the use of NCPs (Nicotine Containing Products).
However, Intellicig, believes MHRA proposals, for distributors to cease marketing within 21
days of their final decision, which is due this summer, as counter-productive to achieving
A Smokefree Future.
With 20,000 regular UK customers of its own, and an estimated 200,000 in total, Intellicig
director David Newns has evidence that a significant proportion will have no option but to
return to regular cigarettes and other tobacco-based nicotine products - with all their proven
health and social damaging effects - if electronic cigarettes are forced from sale at short
notice.
MHRA, in its Consultation Letter MLX 365, The Regulation of Nicotine Containing Products, is
seeking views from more around 200 organisations on its next move and has offered three
options:
· Option 1: Whether NCPs should be considered by MHRA as medicinal and, if so, whether
all products should be removed from the market in 21 days. [Note: This is the MHRA
state preferred option]
· Option 2: Whether NCPs should be considered by MHRA as medicinal and, if so . . . all
marketing must cease by a certain date, eg June 2011. [Note: Option supported by
Intellicig]
· Option 3: Do nothing. Allow market to continue unregulated.
The Government / MHRA stated preferred solution is Option 1, but David Newns believes this
will force thousands of quitters back to their deadly tobacco habit and urges the adoption of
Option 2.
Intellicig has testimonials from users, doctors, nurses and other health professionals, stating
their products have reduced dependency on tobacco and, therefore, transformed lives.
David Newns said: The industry has been operating in the UK for more than four years and
no significant adverse reactions have been reported. This suggests that, although current research
relating to electronic cigarettes is in its infancy, the thousands of user success stories provide a
substantial case for its contribution to A Smokefree Future.
MHRA ultimately wants manufacturers to license their products as medicine, which can be a
lengthy and costly exercise. We support this, because we want Intellicig to be viewed as a
safe and reliable product which helps people reduce their reliance on tobacco. We have invested
heavily in research and were the first company to manufacture our own nicotine cartridges for
electronic cigarettes - EcoPure is British designed, tested and produced in our own UK laboratories.
We are, as requested in A Smokefree Future, providing a radical and innovative alternative
to smoking. It is in our interests that the safety and quality of all electronic cigarettes on the market is
assured.
However, Newns is keen that an option is endorsed following the consultation period
announced this week but one that does not lead to an instant effective ban forcing
thousands of existing user to return to regular cigarettes.
He added: We believe Option 1 will certainly stifle and possibly destroy our opportunity to
achieve licensing, since to cease trading immediately will mean our research and testing will
also have to end. This is currently cited as the MHRAs preferred option in the consultation
paper. Selecting Option 1 will mean that the vast majority of our 20,000 customers will probably
return to tobacco usage in the form of regular cigarettes, in effect making thousands of
people start smoking tobacco again. The Government needs to support smokers to quit,
not take away an effective solution that in their own words is,
considerably safer than smoked tobacco products. (p3 consultation letter)
Of the options proposed, we urge the MHRA, Government and the industry to back Option 2,
allowing time for further research,testing and innovation in the NCP sector.
DAVID NEWNS IS AVAILABE FOR INTERVIEW
Contact via Slater PR
1. Background reading:
Consultation Letter MLX 364 The Regulation Of Nicotine Containing Products
Issued by MHRA
February 1, 2010
MLXs: Medicines consultation letters : MHRA
A Smokefree Future
Issued by HM Government
February 1, 2010
http://www.dh.gov.uk/dr_consum_dh/gr...ments/digitala
sset/dh_111789.pdf
2. Keynotes from Consultation letter MLX 364:
· The Consultation Letter MLX 364 seeks to provide a regulatory framework for NCPs (nicotine
containing products).
· Regulation is sought to ensure the safety and quality of NCPs.
· Among these products are electronic cigarettes.
· The letter seeks a response to one of three options.
Option 1: Whether NCPs should be considered by MHRA as medicinal and, if so, whether all
products should be removed from the market in 21 days.
Option 2: Whether NCPs should be considered by MHRA as medicinal and, if so . . . all
marketing must cease by a certain date, eg June 2011.
Option 3: Do nothing. Allow market to continue unregulated.
· Option 1 is the Government / MHRA preferred option.
· Manufacturers will need to go through the process of licensing products as medicines to
secure an MA (marketing authorisation) or cease marketing in the UK.
· Paragraph 22: It is assumed that with the new strategy, A Smokefree Future and the
licensing of these products that number of quitters should increase.
3. Keynotes from A Smokefree Future:
4.28 It is important to recognise that millions of smokers who want to quit . . . will choose to go
cold turkey, the least successful approach to quitting. We also know that many tobacco users are
keen to find safer alternatives to cigarettes, either to help manage their addiction or as a route to
quitting.
4.29 To meet this demand, this strategy introduces a radical approach to quitting and opens more
routes to quitting which we believe will help thousands more smokers to quit successfully. The
new routes will encourage smokers to break their depndance entirely and wil support smokers to:
- Manage their nicotine addiction using a safer alternative product
- dramatically reduce the harmful effects by using a safer alternative to smoking
4.30 Delivering this new approach will require innovation in the regulation of nicotine delivery
medicines.
4. Background on Intellicig
Lancashire-based electronic cigarette manufacturer, Intellicig, has enjoyed an incredible first
year and is looking ahead to add to their growing list of accomplishments.
Having established its manufacturing base in Accrington, Lancashire, just last year, Intellicig
has already registered £1 million in sales worldwide, is available in every pharmacy in Greece
and has become the subject of a lower insurance premiums deal in South Africa.
As part of a nationwide health kick campaign, Intellicig is the only electronic cigarette
company to be given the official seal of approval by the Egyptian Government to sell Intellicig
products in all of the 30,000 pharmacies in Egypt.
Producing the safest, cleanest and most reliable products on the market is Intellicigs mission
and it is this longstanding commitment which has enabled the company to get to where they
are today.
Intellicig has been accepted into one of the world's top centres for biomedical research which
is another positive step forward in the development of their products.
By working in partnership with the University of Manchester Incubator Company (UMIC),
Intellicig has access to state-of-the-art laboratories fully accredited for bioscience and biotech
developments and in-house mentoring and professional services.
Intellicig has already invested heavily in producing their own brand of nicotine liquid e-liquid
right here in the UK, the only company currently doing so.
ECOpure has been achieved through intensive research, testing and stringent quality control
and is distinct from their competitors, who use e-liquid imported from abroad containing
unmonitored chemicals.
Taking up residence in the 86,500 square feet UMIC laboratory will enable the company to
further develop their nicotine solution by performing their own clinical trials on the products.
It is because of their commitment to reinvestment that has seen Intellicig clinch an exclusive
deal which will see their products stocked in more than 10,000 retail outlets nationwide.
Intellicig is the first electronic cigarette company to partner with sales and distribution
experts Innzone Ltd who work closely with major newspaper wholesalers Menzies Distribution
and Smiths News to get upcoming products on the shelves in convenience stores.
Innzone chose Intellicig above their competitors for one reason; they know exactly what is in
an Intellicig electronic cigarette.
This is the same reason why health experts have praised the smoking alternative and is being
suggested to those wanting to quit smoking and have a healthier lifestyle.
By running on ECOpure alone, a mix of just the four ingredients ethyl maltol, glycerol,
deionised water and nicotine, Intellicig becomes a healthier smoking alternative that allows
smokers to again enjoy the freedom to smoke in public places.
A report conducted by Salford University showed that the three raw materials used in
Intellicigs e-liquid has a minimum purity of 99%, a figure that smokers can trust.
HM Government
A SMOKEFREE FUTURE
MHRA Consultation Letter MLX 364
THE REGULATION OF NICOTINE CONTAINING PRODUCTS
From Intellicig, UK manufacturer and marketer of electronic cigarettes.
Media release 05.02.10 For immediate use.
Electronic cigarette manufacturer backs Government call for
regulation but warns against forcing quitters back to deadly habit.
Intellicig, a leading and pioneering supplier of electronic cigarettes nicotine delivery
devices has backed MHRA calls for industry regulation and licensing and is supporting the
Department for Healths A Smokefree Future policy document issued on Monday.
A Smokefree Future calls for a radical and innovative approach to providing safer nicotine
products so that addicts can limit their exposure to the proven health risk of tobacco smoke
with the use of NCPs (Nicotine Containing Products).
However, Intellicig, believes MHRA proposals, for distributors to cease marketing within 21
days of their final decision, which is due this summer, as counter-productive to achieving
A Smokefree Future.
With 20,000 regular UK customers of its own, and an estimated 200,000 in total, Intellicig
director David Newns has evidence that a significant proportion will have no option but to
return to regular cigarettes and other tobacco-based nicotine products - with all their proven
health and social damaging effects - if electronic cigarettes are forced from sale at short
notice.
MHRA, in its Consultation Letter MLX 365, The Regulation of Nicotine Containing Products, is
seeking views from more around 200 organisations on its next move and has offered three
options:
· Option 1: Whether NCPs should be considered by MHRA as medicinal and, if so, whether
all products should be removed from the market in 21 days. [Note: This is the MHRA
state preferred option]
· Option 2: Whether NCPs should be considered by MHRA as medicinal and, if so . . . all
marketing must cease by a certain date, eg June 2011. [Note: Option supported by
Intellicig]
· Option 3: Do nothing. Allow market to continue unregulated.
The Government / MHRA stated preferred solution is Option 1, but David Newns believes this
will force thousands of quitters back to their deadly tobacco habit and urges the adoption of
Option 2.
Intellicig has testimonials from users, doctors, nurses and other health professionals, stating
their products have reduced dependency on tobacco and, therefore, transformed lives.
David Newns said: The industry has been operating in the UK for more than four years and
no significant adverse reactions have been reported. This suggests that, although current research
relating to electronic cigarettes is in its infancy, the thousands of user success stories provide a
substantial case for its contribution to A Smokefree Future.
MHRA ultimately wants manufacturers to license their products as medicine, which can be a
lengthy and costly exercise. We support this, because we want Intellicig to be viewed as a
safe and reliable product which helps people reduce their reliance on tobacco. We have invested
heavily in research and were the first company to manufacture our own nicotine cartridges for
electronic cigarettes - EcoPure is British designed, tested and produced in our own UK laboratories.
We are, as requested in A Smokefree Future, providing a radical and innovative alternative
to smoking. It is in our interests that the safety and quality of all electronic cigarettes on the market is
assured.
However, Newns is keen that an option is endorsed following the consultation period
announced this week but one that does not lead to an instant effective ban forcing
thousands of existing user to return to regular cigarettes.
He added: We believe Option 1 will certainly stifle and possibly destroy our opportunity to
achieve licensing, since to cease trading immediately will mean our research and testing will
also have to end. This is currently cited as the MHRAs preferred option in the consultation
paper. Selecting Option 1 will mean that the vast majority of our 20,000 customers will probably
return to tobacco usage in the form of regular cigarettes, in effect making thousands of
people start smoking tobacco again. The Government needs to support smokers to quit,
not take away an effective solution that in their own words is,
considerably safer than smoked tobacco products. (p3 consultation letter)
Of the options proposed, we urge the MHRA, Government and the industry to back Option 2,
allowing time for further research,testing and innovation in the NCP sector.
DAVID NEWNS IS AVAILABE FOR INTERVIEW
Contact via Slater PR
1. Background reading:
Consultation Letter MLX 364 The Regulation Of Nicotine Containing Products
Issued by MHRA
February 1, 2010
MLXs: Medicines consultation letters : MHRA
A Smokefree Future
Issued by HM Government
February 1, 2010
http://www.dh.gov.uk/dr_consum_dh/gr...ments/digitala
sset/dh_111789.pdf
2. Keynotes from Consultation letter MLX 364:
· The Consultation Letter MLX 364 seeks to provide a regulatory framework for NCPs (nicotine
containing products).
· Regulation is sought to ensure the safety and quality of NCPs.
· Among these products are electronic cigarettes.
· The letter seeks a response to one of three options.
Option 1: Whether NCPs should be considered by MHRA as medicinal and, if so, whether all
products should be removed from the market in 21 days.
Option 2: Whether NCPs should be considered by MHRA as medicinal and, if so . . . all
marketing must cease by a certain date, eg June 2011.
Option 3: Do nothing. Allow market to continue unregulated.
· Option 1 is the Government / MHRA preferred option.
· Manufacturers will need to go through the process of licensing products as medicines to
secure an MA (marketing authorisation) or cease marketing in the UK.
· Paragraph 22: It is assumed that with the new strategy, A Smokefree Future and the
licensing of these products that number of quitters should increase.
3. Keynotes from A Smokefree Future:
4.28 It is important to recognise that millions of smokers who want to quit . . . will choose to go
cold turkey, the least successful approach to quitting. We also know that many tobacco users are
keen to find safer alternatives to cigarettes, either to help manage their addiction or as a route to
quitting.
4.29 To meet this demand, this strategy introduces a radical approach to quitting and opens more
routes to quitting which we believe will help thousands more smokers to quit successfully. The
new routes will encourage smokers to break their depndance entirely and wil support smokers to:
- Manage their nicotine addiction using a safer alternative product
- dramatically reduce the harmful effects by using a safer alternative to smoking
4.30 Delivering this new approach will require innovation in the regulation of nicotine delivery
medicines.
4. Background on Intellicig
Lancashire-based electronic cigarette manufacturer, Intellicig, has enjoyed an incredible first
year and is looking ahead to add to their growing list of accomplishments.
Having established its manufacturing base in Accrington, Lancashire, just last year, Intellicig
has already registered £1 million in sales worldwide, is available in every pharmacy in Greece
and has become the subject of a lower insurance premiums deal in South Africa.
As part of a nationwide health kick campaign, Intellicig is the only electronic cigarette
company to be given the official seal of approval by the Egyptian Government to sell Intellicig
products in all of the 30,000 pharmacies in Egypt.
Producing the safest, cleanest and most reliable products on the market is Intellicigs mission
and it is this longstanding commitment which has enabled the company to get to where they
are today.
Intellicig has been accepted into one of the world's top centres for biomedical research which
is another positive step forward in the development of their products.
By working in partnership with the University of Manchester Incubator Company (UMIC),
Intellicig has access to state-of-the-art laboratories fully accredited for bioscience and biotech
developments and in-house mentoring and professional services.
Intellicig has already invested heavily in producing their own brand of nicotine liquid e-liquid
right here in the UK, the only company currently doing so.
ECOpure has been achieved through intensive research, testing and stringent quality control
and is distinct from their competitors, who use e-liquid imported from abroad containing
unmonitored chemicals.
Taking up residence in the 86,500 square feet UMIC laboratory will enable the company to
further develop their nicotine solution by performing their own clinical trials on the products.
It is because of their commitment to reinvestment that has seen Intellicig clinch an exclusive
deal which will see their products stocked in more than 10,000 retail outlets nationwide.
Intellicig is the first electronic cigarette company to partner with sales and distribution
experts Innzone Ltd who work closely with major newspaper wholesalers Menzies Distribution
and Smiths News to get upcoming products on the shelves in convenience stores.
Innzone chose Intellicig above their competitors for one reason; they know exactly what is in
an Intellicig electronic cigarette.
This is the same reason why health experts have praised the smoking alternative and is being
suggested to those wanting to quit smoking and have a healthier lifestyle.
By running on ECOpure alone, a mix of just the four ingredients ethyl maltol, glycerol,
deionised water and nicotine, Intellicig becomes a healthier smoking alternative that allows
smokers to again enjoy the freedom to smoke in public places.
A report conducted by Salford University showed that the three raw materials used in
Intellicigs e-liquid has a minimum purity of 99%, a figure that smokers can trust.